Rocuronium Bromide Injection, Solution
Product Images NDC 71872-7344

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 71872-7344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7344.pdp (7344)

7344.pdp (7344)
Label for Rocuronium Bromide Injection 10 mg/mL solution in a 5 mL multiple dose vial. The label states it is for intravenous use only and includes warnings, storage instructions to refrigerate between 2-8°C, and manufacturer details: Caplin Steriles Limited, India. Distributed by Medical Purchasing Solutions, Scottsdale, AZ.*
FDA Label Image

7344m.pdp (7344m)

7344m.pdp (7344m)
Label for Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) in a 5 mL multiple-dose vial. The label highlights it is sterile and nonpyrogenic, for intravenous use only, and includes a warning about its paralytic effects causing respiratory arrest. It is manufactured by Caplin Steriles Limited, India, and distributed by BE Pharmaceuticals Inc.*
FDA Label Image

Figure1 (Rocurofigure1)

Figure1 (Rocurofigure1)
A scatter plot graph depicting time in minutes on the vertical axis and dosage in mg/kg on the horizontal axis. The horizontal axis is divided into three age groups: 18-64 years, 65 years and older, and 1-12 years, with dosage values ranging from 0.45 to 1.2 mg/kg for adults and 0.6 mg/kg for children. Data points with outliers are scattered across the time range for each dosage and age group.*
FDA Label Image

Figure2 (Rocurofigure2)

Figure2 (Rocurofigure2)
A box-and-whisker plot showing data distribution of minutes versus dosage levels in mg/kg across different age groups (18-64 years, 65 years and older, 3 months to 1 year, 1 to 12 years). The plot displays varying ranges and medians of minutes for each dosage and age group category.*
FDA Label Image

Figure3 (Rocurofigure3)

Figure3 (Rocurofigure3)
A line graph depicting the relationship between dose number (x-axis) and minutes (y-axis) for Rocuronium Bromide at two dosage levels: 0.15 mg/kg and 0.1 mg/kg. The graph includes data points connected by lines, showing time changes across five doses, with sample sizes (N=13 and N=29) indicated for each dosage group.*
FDA Label Image

Structure (Rocurostrucaplin)

Structure (Rocurostrucaplin)
Chemical structure of rocuronium bromide, showing its molecular framework with functional groups including a quaternary ammonium ion and bromide anion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.